Background: Myocardial fibrosis reflects excess collagen deposition in the extracellular left ventricular (LV) matrix which has been associated with heart failure (HF). No studies have addressed the relation between fibrosis biomarkers and HF in the elderly. Methods and Results: Serum fibrosis markers were measured in 880 participants of the Cardiovascular Health Study (mean age 77 6 yrs, 48% female). Participants with systolic HF (n=179, LV ejection fraction < 55%) and those with diastolic HF (n=131, LV ejection fraction 55%) were compared to controls (280 with cardiovascular risk factors, and 279 healthy individuals) using a nested case-control design. Fibrosis markers included carboxyl-terminal peptide of procollagen type I (PIP), carboxyl-terminal telopeptide of collagen type I (CITP), and amino-terminal peptide of procollagen type III (PIIINP). Echocardiography was used to document systolic and diastolic function parameters. Analysis of variance and logistic regression (per tertile odds ratios: OR), adjusted by age, gender, race, hypertension, atrial fibrillation, coronary heart disease, baseline serum glucose, serum cystatin C, serum creatinine, C-reactive protein, any ACE inhibitor, spironolactone or any diuretic, NT-proBNP and total bone mineral density were performed.
1.2-5.7) and PIIINP (OR = 3.3; 95% CI = 1.6 -5.8), when adjusting for covariates.
Associations of diastolic HF were significant for CITP (OR = 3.9, 95% CI = 1.9-8. 3 ) and PIIINP (OR = 2.7; 95% CI = 1.4-5.4). HF was not associated with mino-terminal peptide of procollagen type III (PIIINP). Echocardiography
INTRODUCTION
Myocardial connective tissue plays an important role in defining and preserving normal myocardial architecture and function (1) . Excess deposition of collagen in extracellular matrix can lead to increased myocardial stiffness and subsequently to cardiac hypertrophy and left ventricular dysfunction. These pathological changes increase the risk of heart failure and provide an anatomic substrate for life-threatening cardiac arrhythmias (1, 2) . Type I and III collagens are the major fibrillar collagens in both normal and diseased myocardium (3) (4) . Both are synthesized as procollagens with a small amino terminal and a larger carboxy terminal propeptide. Serum markers of fibrosis reflecting collagen synthesis include carboxy-terminal propeptide of type I procollagen (PIP) and aminoterminal propeptide of type III procollagen (PIIINP), and degradation markers include carboxy-terminal telopeptide of collagen type I (CITP). Elevations in these fibrosis markers have been shown to reflect intra-myocardial collagen turnover (5) (6) .
Increased collagen synthesis/degradation has been found in heart failure (HF) (5) (6) , but the effect of aging on myocardial fibrosis and the role of fibrosis in diastolic and systolic HF in the elderly has not been established. We therefore in the elderly and is associated with increases in fibrosis markers (8-10), we also examined the influence of bone mineral density on the relation between HF and fibrosis markers.
METHODS

Participants and study design
The Cardiovascular Health Study (CHS) is a prospective, communitybased, epidemiologic observational study designed to assess cardiovascular risk factors and outcomes in individuals 65 years old. The design and the rationale of the CHS have been published elsewhere (11). Briefly, 5,201 participants 65 years old were enrolled in 1989 and 1990, with an additional cohort of 687 ethnic minority participants enrolled in 1992 and 1993. Exclusion criteria were: hospice treatment, wheel-chair bound in the home, and radiation or chemotherapy for cancer. For purposes of the present study, history of chronic liver disease or pulmonary disease were used as additional exclusion criteria to minimize confounding effects of these diseases on fibrosis markers. The baseline examination (1989) (1990) and HF with preserved systolic function (diastolic HF) as a positive history of HF with a LVEF 55% (7).
Determination of plasma CITP, PIP, and PIIINP
Phlebotomy methods, blood processing, and handling of samples have been described previously (11). Aliquots were frozen at -70°C until analysis.
CITP was measured using the CITP RIA from Orion Diagnostica on serum samples. Intra-and inter-assay variability are 3.5-9.5% and 5.6-9.0%, respectively. The lower detection limit is 0.4 ug/L.
PIP was measured using an enzyme immunoassay kit (Takara Mirus Bio
Inc., Madison, WI). The assay range is 10 -640 μg/L with a lower detection limit of 10 μg/L. Intra-assay and inter-assay CVs range from 4.5-7.4% and 4.3-6.3%, respectively.
PIIINP was determined by a coated-tube radioimmunoassay as described previously by Risteli et al (13), using commercial antisera specifically directed against the terminal amino terminal peptide (Orion Diagnostica, Finland). The interassay and intra-assay variations for determining PIIIP are both about 5%.
The sensitivity (lower detection limit) is 1.5 ng /mL. PIIINP was determined by a coated tube radioimmunoassay as describe and utilization of QDR software was based on the manufacturer's recommended protocol. Scans were read blindly at the University of California, San Francisco reading center with Hologic software version 7.10 (14).
Bone mineral density
NT-proBNP
This biomarker was measured in serum collected in 1992-1993 from the main CHS and supplementary minority cohorts and measured on the Table 1 shows demographic, clinical and laboratory variables. Compared to the healthy control group, participants in the HF groups had higher prevalence of coronary heart disease, stroke, atrial fibrillation, and worse metabolic, renal and inflammatory measures. ACE-inhibitors and diuretics were used more in the HF groups compared to both control groups whereas the difference between participants with HF and controls in the use of potassium-sparing agents did not reach statistical significance.
RESULTS
Subjects characteristics
The median and interquartile range of the fibrosis markers in the 4 analyzed groups are illustrated in the figures 1-3.
Relationship between heart failure and fibrosis markers
CITP and PIIINP were significantly higher in both HF groups compared to both control groups (p < 0.0001), whereas differences in PIP were not significant (p= 0.40). No differences were found between systolic HF versus diastolic HF 2.9, respectively; Table 2 ). Diastolic HF was associated with increased prevalence of elevated CITP and PIIINP (OR per tertile = 3.8 and 2.5, respectively).
Association of Serum Fibrosis Markers with Age, Gender, and Race
No association was found between age and fibrosis markers in participants with systolic HF. Among individuals with diastolic HF, CITP was associated with age (r =0.15, p = 0.05). Similar results were found for CITP in controls with cardiovascular risk factors (r= 0.27, p < 0.0001) and in healthy controls (r = 0.19, p = 0.001). PIP was associated with age in participants with diastolic HF (r = 0.25, p=0.001), but not in other groups. PIIINP was weakly associated with age in the control group (r = 0.12, p = 0.04).
In systolic HF, males had higher PIIINP levels than females (5.3 vs.
3.7μg/L, p = 0.0002) whereas, in diastolic HF, females had higher levels of PIP than males (419 vs. 370 μg/L, p = 0.03). These same relationships were maintained in controls, where PIP was also higher in females than in males (431 vs. 380 μg/L, p =0.001) and serum levels of PIIINP were higher in males than in females (3.3 vs. 2.9 μg/L, p = 0.004). No gender differences in fibrosis markers were observed among healthy controls.
Differences between White versus Black participants were observed only in the healthy control group: CITP and PIIINP were higher in Black than in White participants (4.7 vs. 4.1 μg/L, p = 0.04 and 4.3 vs. 3.5 μg/L, p = 0.002, respectively).
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/L p = 0 0002) whereas in diastolic HF females had higher levels of PIP Table 3 presents the echocardiographic variables analyzed and the comparison of their mean values between the 4 groups. In general, there was a modest correlation between the echo-Doppler variables and fibrosis markers. The strongest correlations were between PIP with LVEF (r = -0.22, p =0.007), CITP with interventricular septum diastolic thickness (IVS) (r = 0.23, p= 0.01) and PIIINP with IVS (r = 0.25, p = 0.006) in the participants with DHF. In the control group, PIIINP was associated with LA diameter (r = 0.15, p =0.02). In the healthy control group, the only association was found between PIIINP with peak velocity of E wave (r = 0.18, p = 0.01), and in the participants with SHF, no association was found between fibrosis markers and the echo-Doppler parameters. Inflammatory markers included C-reactive protein (CRP) and fibrinogen (Table 4 ). In the systolic HF group, PIP was inversely correlated with CRP and fibrinogen, whereas other correlations were non-significant. In diastolic HF, PIP was inversely associated with CRP and PIIINP with fibrinogen. In the control 0.15, , p p p p p =0.02). ) In n n n n n n th th t t t t t Of all 3 markers evaluated, only CITP and PIIINP were associated with heart failure when adjusted for NT-proBNP (p=0.01 and 0.003, respectively).
Association of Fibrosis Markers with Echocardiographic Variables
Association of Fibrosis Markers with Renal Function, Inflammatory Markers, NT-proBNP and Total Bone Mineral Density
There were significant differences in total bone mineral density between systolic HF and healthy controls (p = 0.0002) and between healthy control and heart failure free control groups (p<0.0001). However, total bone mineral density which was slightly increased in systolic HF group, was significantly correlated with CITP in these participants (r = 0.47, p= 0.007). No other significant associations between the total bone mineral density and fibrosis markers were 3 markers evaluated only CITP and PIIINP were associated with heart this relationship and did to contribute to the increase in CITP and PIIINP in HF patients.
DISCUSSION
The principal finding of this study is that serum markers (21) . The structure of collagen is also changed with aging. In a pathoanatomic study, the perimysial and endomysial collagen type I fibers was found to be increased in number and thickness in older hearts (22) . The present investigation found that the ratio of PIP/CITP which reflects collagen type I turnover was lower in participants with HF than healthy controls, which was primarily due to higher levels of CITP in those with HF. An explanation for specific increase in CITP and PIIINP might be that in the early phase of Alternatively, our failure to find and association of PIP with HF, may reflect an elderly population where the degradation of collagen type I prevails over its synthesis. A shift from type I to type III collagen synthesis has been demonstrated in non-human primate models of arterial hypertension (3, 4) .
It is also possible, that in our elderly population synthesis of type I collagen may have reached a plateau. In support of this is that PIP levels in our healthy control and control groups was much greater than that seen in normal individuals in other studies using the same method of measurement, and approximated that which was reported for diastolic HF including those with advanced diastolic dysfunction (18). Further research is needed into the dynamic changes of various components of the fibrosis process in progressive HF.
Systolic vs. Diastolic Heart Failure
In contrast to the serum levels of NT-proBNP which differed between SHF and DHF, collagen markers were similar in both types of HF. This finding was unanticipated because systolic HF is associated with a higher prevalence of coronary heart disease and prior myocardial revascularization than diastolic HF.
Hence we anticipated that systolic HF would be associated with higher burden of fibrosis. The participants with diastolic HF had a higher prevalence of hypertension than those with systolic HF, and a significant albeit modest implying that mechanisms related to the pathogenesis of arterial hypertension could lead to increased collagen synthesis and degradation. While we did not evaluate functional class of HF in the CHS, a previous study of HF with low ejection fraction did not find an association between markers of collagen turnover and NYHA functional class (23) . Our findings support those of others (24) in showing absent or weak correlations between PIIINP and echocardiographic variables.
Inflammation, Renal Dysfunction, Total Bone Mineral Density and NT pro-BNP as
Related to Fibrosis Markers
Inflammation is a plausible etiology mediating fibrosis (25) . An inverse association between PIP with fibrinogen and CRP, and between PIIINP with fibrinogen were observed in the HF groups which has not been previously reported. The mechanisms of this finding require further investigation.
Decreases in renal function may decrease the clearance of biomarkers and confound the association between fibrosis markers and heart failure. We found that cystatin C, a sensitive marker of renal dysfunction in the elderly (26) was associated only with CITP and PIIINP (Table 4 ) but not with PIP. Additionally, renal dysfunction could be mechanistically linked to increases in myocardial interstitial matrix formation, thereby promoting HF. However, in the present study, the relation of HF to fibrosis markers was independent of cystatin C. 
